Cancer Family
Digestive System Neoplasm
CI-CAN-00000012Explore in graph →
Non-malignant4,732 active trials43 approved drugs557 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000012Explore in graph →
Clinical trials
22,051 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00136669 | Acupuncture For Pancreatic Cancer Pain | completed | Phase 3 | 60 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 8, 2006 | clinicaltrials |
| NCT00355212 | Comparison Between Radiofrequency Versus Ethanol Injection for the Treatment of Hepatocellular Carcinoma | terminated | Phase 3 | 240 | Azienda Ospedaliera San Giovanni BattistaOTHER | 1 | Jul 25, 2006 | clinicaltrials |
| NCT00035035 | A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas. | completed | Phase 3 | — | Eli Lilly and CompanyINDUSTRY | 18 | Jul 19, 2006 | clinicaltrials |
| NCT00290524 | Early Alimentation Following Colorectal Surgery | unknown | Phase 3 | 800 | Maisonneuve-Rosemont HospitalOTHER | 1 | Apr 7, 2006 | clinicaltrials |
| NCT00309517 | Randomized Study on Neoadjuvant Radio-Chemotherapy in Rectal Carcinoma Dukes B and C | terminated | Phase 3 | 700 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Apr 3, 2006 | clinicaltrials |
| NCT00309530 | Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C | completed | Phase 3 | 598 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Apr 3, 2006 | clinicaltrials |
| NCT00309543 | Randomized Trial on Adjuvant Chemotherapy in Colon Carcinoma Dukes B | completed | Phase 3 | 636 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Apr 3, 2006 | clinicaltrials |
| NCT00295035 | Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon Cancer | unknown | Phase 3 | 100 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 0 | Feb 22, 2006 | clinicaltrials |
| NCT00088660 | PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen | unknown | Phase 3 | 250 | Therion Biologics CorporationINDUSTRY | 1 | Feb 8, 2006 | clinicaltrials |
| NCT00193817 | Three Field Radical Esophagectomy Versus Two Field Esophagectomy - a Prospective Trial | unknown | Phase 3 | 700 | Tata Memorial HospitalOTHER_GOV | 1 | Feb 7, 2006 | clinicaltrials |
| NCT00273247 | Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis | completed | Phase 3 | 150 | National Cancer Institute, MilanOTHER | 1 | Jan 9, 2006 | clinicaltrials |
| NCT00149565 | Phase Ⅲ Randomized Trial in Postoperative Hepatocellular Carcinoma | completed | Phase 3 | 268 | National Health Research Institutes, TaiwanOTHER | 1 | Dec 16, 2005 | clinicaltrials |
| NCT00165048 | Selective COX-II Inhibitor as a Palliative Therapy in Patients With R1 or R2 Resection for Disseminated Stomach Cancer - A Multi-Centre Prospective Randomized Controlled Trial | unknown | Phase 3 | 206 | Chinese University of Hong KongOTHER | 1 | Dec 9, 2005 | clinicaltrials |
| NCT00260884 | Phase III Study OF the Gastric Surgery on Advanced Stage Gastric Cancer | completed | Phase 3 | 220 | National Health Research Institutes, TaiwanOTHER | 0 | Dec 2, 2005 | clinicaltrials |
| NCT00154752 | Concurrent Chemoradiation Versus Wide Pelvic Lymphadenectomy for Advanced Rectal Cancer | unknown | Phase 3 | 200 | National Taiwan University HospitalOTHER | 1 | Nov 22, 2005 | clinicaltrials |
| NCT00164892 | Selective COX-II Inhibitor as an Adjuvant Therapy in Patients With Resectable Advanced Stomach Cancer ( Histological Staging ≥ T2N1) - A Multi-Centre Prospective Randomised Controlled Trial | unknown | Phase 3 | 214 | Chinese University of Hong KongOTHER | 1 | Nov 17, 2005 | clinicaltrials |
| NCT00121914 | Treatment of Hepatocellular Carcinoma: Long-Acting Somatostatin Plus Percutaneous Ethanol Instillation (PEI) Versus Long-Acting Somatostatin Alone | unknown | Phase 3 | 120 | Medical University of ViennaOTHER | 1 | Oct 18, 2005 | clinicaltrials |
| NCT00212589 | Patients Preference for Oral or i.v. Therapy | completed | Phase 3 | 60 | Odense University HospitalOTHER | 1 | Sep 21, 2005 | clinicaltrials |
| NCT00189657 | 5FU/VL Vs LV5FU2 + CPT11 in Stage II-III Resected Rectal Cancer | unknown | Phase 3 | — | Association Européenne de Recherche en OncologieOTHER | 1 | Sep 19, 2005 | clinicaltrials |
| NCT00189683 | Xeloda Vs Monitoring in Advanced Colorectal Cancer Responsive to Chemotherapy | unknown | Phase 3 | — | Association Européenne de Recherche en OncologieOTHER | 1 | Sep 19, 2005 | clinicaltrials |
| NCT00164918 | Role of Routine Nasogastric Decompression After Subtotal Gastrectomy | unknown | Phase 3 | 90 | Chinese University of Hong KongOTHER | 1 | Sep 14, 2005 | clinicaltrials |
| NCT00165061 | Multi-Center Prospective Randomized Trial Comparing Standard Esophagectomy Against Chemo-Radiotherapy for Treatment of Squamous Esophageal Cancer - Early Results From the Chinese University Research Group for Esophageal Cancer (CURE) | completed | Phase 3 | 80 | Chinese University of Hong KongOTHER | 1 | Sep 14, 2005 | clinicaltrials |
| NCT00119899 | Utility of FDG-PET Scan on the Selection of Patients for Resection of Hepatic Colorectal Metastases | completed | Phase 3 | 150 | Radboud University Medical CenterOTHER | 1 | Aug 31, 2005 | clinicaltrials |
| NCT00034333 | Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads Vs. IV Doxorubicin in Treating Liver Cancer | terminated | Phase 2 / Phase 3 | 240 | FeRxINDUSTRY | 8 | Jun 24, 2005 | clinicaltrials |
| NCT00057382 | T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients | terminated | Phase 2 / Phase 3 | 750 | TularikINDUSTRY | 11 | Jun 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Sep 8, 2006source: clinicaltrials